USD 24.34
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 5.66 Billion JPY | 9990.19% |
2023 | 57.7 Million JPY | -27.32% |
2022 | 79.4 Million JPY | 13609.99% |
2021 | 579.18 Thousand JPY | -64.27% |
2020 | 1.62 Million JPY | -37.04% |
2019 | 2.57 Million JPY | -31.37% |
2018 | 3.75 Million JPY | -17.7% |
2017 | 4.55 Million JPY | -99.65% |
2016 | 1.29 Billion JPY | -79.3% |
2015 | 6.23 Billion JPY | 1958.42% |
2014 | 303 Million JPY | 31.17% |
2013 | 231 Million JPY | -51.77% |
2012 | 479 Million JPY | -63.3% |
2011 | 1.3 Billion JPY | -38.06% |
2010 | 2.1 Billion JPY | -37.53% |
2009 | 3.37 Billion JPY | -16.26% |
2008 | 4.02 Billion JPY | -19.3% |
2007 | 4.99 Billion JPY | 713.83% |
2006 | 613.26 Million JPY | -93.89% |
2005 | 10.03 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | 5.66 Billion JPY | 9721.6% |
2024 Q1 | 49.65 Million JPY | -13.96% |
2024 Q2 | 44.61 Million JPY | -10.15% |
2024 Q4 | 5.66 Billion JPY | 12866.51% |
2024 Q3 | 43.71 Million JPY | -2.02% |
2023 Q3 | 62.26 Million JPY | 4.01% |
2023 FY | 57.7 Million JPY | -27.32% |
2023 Q4 | 57.7 Million JPY | -7.32% |
2023 Q1 | 67.49 Million JPY | -15.0% |
2023 Q2 | 59.86 Million JPY | -11.31% |
2022 Q4 | 79.4 Million JPY | 0.0% |
2022 FY | 79.4 Million JPY | 13609.99% |
2022 Q3 | - JPY | 0.0% |
2022 Q1 | 576.62 Thousand JPY | -99.83% |
2022 Q2 | - JPY | -100.0% |
2021 Q2 | 121 Million JPY | -30.86% |
2021 Q4 | 330 Million JPY | 172.73% |
2021 Q3 | 121 Million JPY | 0.0% |
2021 FY | 579.18 Thousand JPY | -64.27% |
2021 Q1 | 175 Million JPY | -76.57% |
2020 Q4 | 747 Million JPY | 224.78% |
2020 Q1 | 285 Million JPY | -82.59% |
2020 FY | 1.62 Million JPY | -37.04% |
2020 Q2 | 230 Million JPY | -19.3% |
2020 Q3 | 230 Million JPY | 0.0% |
2019 Q4 | 1.63 Billion JPY | 380.06% |
2019 Q2 | 341 Million JPY | -14.54% |
2019 Q1 | 399 Million JPY | -52.78% |
2019 Q3 | 341 Million JPY | 0.0% |
2019 FY | 2.57 Million JPY | -31.37% |
2018 Q3 | 453 Million JPY | 0.0% |
2018 Q1 | 508 Million JPY | -63.27% |
2018 FY | 3.75 Million JPY | -17.7% |
2018 Q4 | 845 Million JPY | 86.53% |
2018 Q2 | 453 Million JPY | -10.83% |
2017 Q3 | 566 Million JPY | 0.0% |
2017 Q2 | 566 Million JPY | 0.0% |
2017 Q1 | - JPY | -100.0% |
2017 FY | 4.55 Million JPY | -99.65% |
2017 Q4 | 1.38 Billion JPY | 144.35% |
2016 Q3 | - JPY | 0.0% |
2016 FY | 1.29 Billion JPY | -79.3% |
2016 Q4 | 1.29 Billion JPY | 0.0% |
2016 Q2 | - JPY | 0.0% |
2016 Q1 | - JPY | -100.0% |
2015 FY | 6.23 Billion JPY | 1958.42% |
2015 Q4 | 6.23 Billion JPY | 0.0% |
2015 Q1 | - JPY | -100.0% |
2015 Q2 | - JPY | 0.0% |
2015 Q3 | - JPY | 0.0% |
2014 Q4 | 303 Million JPY | 0.0% |
2014 Q3 | - JPY | 0.0% |
2014 Q2 | - JPY | 0.0% |
2014 Q1 | - JPY | -100.0% |
2014 FY | 303 Million JPY | 31.17% |
2013 FY | 231 Million JPY | -51.77% |
2013 Q3 | - JPY | 0.0% |
2013 Q1 | - JPY | -100.0% |
2013 Q2 | - JPY | 0.0% |
2013 Q4 | 231 Million JPY | 0.0% |
2012 Q4 | 479 Million JPY | 0.0% |
2012 FY | 479 Million JPY | -63.3% |
2012 Q3 | - JPY | -100.0% |
2012 Q1 | 500 Million JPY | -61.69% |
2012 Q2 | 425 Million JPY | -15.0% |
2011 Q3 | 1 Billion JPY | -29.82% |
2011 Q4 | 1.3 Billion JPY | 30.5% |
2011 FY | 1.3 Billion JPY | -38.06% |
2011 Q1 | 1.5 Billion JPY | -28.81% |
2011 Q2 | 1.42 Billion JPY | -5.0% |
2010 Q2 | 2.42 Billion JPY | 0.0% |
2010 Q3 | 2 Billion JPY | -17.53% |
2010 FY | 2.1 Billion JPY | -37.53% |
2010 Q4 | 2.1 Billion JPY | 5.35% |
2009 Q4 | 3.37 Billion JPY | 12.43% |
2009 FY | 3.37 Billion JPY | -16.26% |
2009 Q3 | 3 Billion JPY | 0.0% |
2008 FY | 4.02 Billion JPY | -19.3% |
2007 FY | 4.99 Billion JPY | 713.83% |
2006 FY | 613.26 Million JPY | -93.89% |
2005 FY | 10.03 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | -1133500.0% |
Ansell Limited | 855.59 Million USD | -562.463% |
Ansell Limited | 857.2 Million USD | -561.223% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | -25190.516% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 20.93 Thousand USD | -27074177.526% |
Psykey, Inc. | 1.01 Million USD | -560754.938% |
ConvaTec Group Plc | 1.31 Billion USD | -332.491% |
ConvaTec Group Plc | 1.31 Billion USD | -331.881% |
Encision Inc. | 1.33 Million USD | -425041.876% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | -245404.321% |
Innovative MedTech Inc. | 1.87 Million USD | -301674.282% |
LifePoint, Inc. | 446.74 Thousand USD | -1268646.922% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -104976.173% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | -258831.019% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 242.64 Thousand USD | -2335832.477% |
SmileDirectClub, Inc. | 871.79 Million USD | -550.151% |
Sector 10, Inc. | 164 Thousand USD | -3455997.561% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | -740.935% |
SheerVision, Inc. | 75 Thousand USD | -7557233.333% |
United Health Products, Inc. | 755.98 Thousand USD | -749646.359% |
Vasamed, Inc. | 23.45 Thousand USD | -24170475.693% |
Wearable Health Solutions, Inc. | 2.76 Million USD | -204715.402% |
Yubo International Biotech Limited | 790.49 Thousand USD | -716915.455% |